163 related articles for article (PubMed ID: 32637655)
1. Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.
Court CM; Hou S; Liu L; Winograd P; DiPardo BJ; Liu SX; Chen PJ; Zhu Y; Smalley M; Zhang R; Sadeghi S; Finn RS; Kaldas FM; Busuttil RW; Zhou XJ; Tseng HR; Tomlinson JS; Graeber TG; Agopian VG
NPJ Precis Oncol; 2020; 4():16. PubMed ID: 32637655
[TBL] [Abstract][Full Text] [Related]
2. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
3. Low-cost and clinically applicable copy number profiling using repeat DNA.
Abujudeh S; Zeki SS; van Lanschot MCJ; Pusung M; Weaver JMJ; Li X; Noorani A; Metz AJ; Bornschein J; Bower L; Miremadi A; Fitzgerald RC; Morrissey ER; Lynch AG
BMC Genomics; 2022 Aug; 23(1):599. PubMed ID: 35978291
[TBL] [Abstract][Full Text] [Related]
4. Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.
Beasley A; Isaacs T; Khattak MA; Freeman JB; Allcock R; Chen FK; Pereira MR; Yau K; Bentel J; Vermeulen T; Calapre L; Millward M; Ziman MR; Gray ES
JCO Precis Oncol; 2018; 2():. PubMed ID: 32913999
[TBL] [Abstract][Full Text] [Related]
5. Genomic determinants of somatic copy number alterations across human cancers.
Zhang Y; Xu H; Frishman D
Hum Mol Genet; 2016 Mar; 25(5):1019-30. PubMed ID: 26732428
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
7. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
8. Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas.
Harbers L; Agostini F; Nicos M; Poddighe D; Bienko M; Crosetto N
Front Oncol; 2021; 11():700568. PubMed ID: 34395272
[TBL] [Abstract][Full Text] [Related]
9. Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer.
Soh J; Cho H; Choi CH; Lee H
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30501131
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns.
Luo S; Zhang Y; Jia Y; Zhang X
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12831. PubMed ID: 35767937
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
Wang C; Luo Q; Huang W; Zhang C; Liao H; Chen K; Pan M
Front Oncol; 2021; 11():686365. PubMed ID: 34178679
[TBL] [Abstract][Full Text] [Related]
12. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
15. Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Kou F; Wu L; Guo Y; Zhang B; Li B; Huang Z; Ren X; Yang L
Cancer Biol Med; 2021 Aug; 19(5):685-95. PubMed ID: 34448554
[TBL] [Abstract][Full Text] [Related]
16. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
18. Comparison of EpCAM
Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
[TBL] [Abstract][Full Text] [Related]
19. Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.
Sun N; Lee YT; Kim M; Wang JJ; Zhang C; Teng PC; Qi D; Zhang RY; Tran BV; Lee YT; Ye J; Palomique J; Nissen NN; Han SB; Sadeghi S; Finn RS; Saab S; Busuttil RW; Posadas EM; Liang L; Pei R; Yang JD; You S; Agopian VG; Tseng HR; Zhu Y
Adv Mater Technol; 2021 May; 6(5):. PubMed ID: 34212072
[TBL] [Abstract][Full Text] [Related]
20. Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma.
Davidson M; Barber LJ; Woolston A; Cafferkey C; Mansukhani S; Griffiths B; Moorcraft SY; Rana I; Begum R; Assiotis I; Matthews N; Rao S; Watkins D; Chau I; Cunningham D; Starling N; Gerlinger M
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
